TEL AVIV, ISRAEL – Animal-free dairy developer Remilk announced it received a “no questions letter" from the US Food and Drug Administration, as well as regulatory approval from the Singapore Food Authority (SFA).
The letter from the FDA gave Remilk the official word that an expert panel unanimously agreed the company’s animal-free whey protein can safely be used in food products under the FDA’s generally recognized as safe (GRAS) standards.
The Israel-based company, which uses a precision fermentation process to create its protein, in 2022 shared its self-affirmed GRAS status.
Per Remilk, its protein is identical to traditional whey protein that is derived from cow milk, making products that include the animal-free protein “indistinguishable in taste and function” from traditional dairy. Plus, the animal-free protein allows for dairy products to be free from lactose, cholesterol and hormones.
The company said its newly acquired SFA approval opens Remilk to the Singapore market, which is considered a world leader in the adoption of alternate protein products.
"Both SFA's approval and the ‘no questions letter’ we received from the FDA serve as further proof that our animal-free milk protein is bioidentical to its cow-derived counterpart and safe for consumption,” said Aviv Wolff, the company’s co-founder and chief executive officer. "Humans have consumed milk proteins as a staple source of high-quality nutrition for millennia. Remilk's animal-free protein maintains these great benefits, enabling us to reinvent dairy that is kinder and significantly more sustainable. We take pride in these regulatory approvals and look forward to a continued global focus on unlocking the future of food.”